Desq Long
Sign in

Company

Metagenomi Therapeutics, Inc.

MGX · CIK 0001785279

SEC FORM 4
$23,263.11

Metagenomi Therapeutics, Inc. (MGX)

Purchase of 19,883 shares at $1.17 per share.

Reporting Person Reid Laurence · Transaction Code P

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001193125-26-389550 · filed 2026-09-11 · View filing →

SEC FORM 4
$138.06

Metagenomi Therapeutics, Inc. (MGX)

Purchase of 117 shares at $1.18 per share.

Reporting Person Reid Laurence · Transaction Code P

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001193125-26-389550 · filed 2026-09-11 · View filing →

SEC FORM 4
$2,213.70

Metagenomi Therapeutics, Inc. (MGX)

Sale of 1,911 shares at $1.1584 per share.

Reporting Person Wapnick Pamela · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001193125-26-387786 · filed 2026-09-10 · View filing →

SEC FORM 4
$2,478.98

Metagenomi Therapeutics, Inc. (MGX)

Sale of 2,140 shares at $1.1584 per share.

Reporting Person Irish Jian · Officer Title See Remarks · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001193125-26-387798 · filed 2026-09-10 · View filing →

SEC FORM 4
$414.71

Metagenomi Therapeutics, Inc. (MGX)

Sale of 358 shares at $1.1584 per share.

Reporting Person Wein Matthew · Officer Title See Remarks · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001193125-26-387816 · filed 2026-09-10 · View filing →